Hematopoietic Cell Transplantation clinical trials
36 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
- Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
- Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- Massage Impact on Sleep in Pediatric Oncology
- Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
- Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
- Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
- PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
- A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
- The Collection and Storage of Umbilical Cord Blood for Transplantation
- Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy
- Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
- Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
- Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
- TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
- T Cell Therapy of Opportunistic Cytomegalovirus Infection
- BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron
- Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
- The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
- Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
- Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
- A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
- Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation
- Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
- Virtual Rehabilitation in HCT
- Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
- Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study
- Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
- Nutrition OUtReach In Systems of Healthcare
- Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplant
- ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant Patients
- Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hematopoietic Cell Transplantation” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.